Browsing Category

63945 posts
Kardex and Addverb start partnership in the area of intralogistics software

Kardex and Addverb start partnership in the area of intralogistics software

ZURICH, Jan. 23, 2024 /PRNewswire/ — Kardex has agreed a strategic partnership…
Magnolia received the Outstanding Digital Service Provider for the Consumer Goods Industry Award

Magnolia received the Outstanding Digital Service Provider for the Consumer Goods Industry Award

SHANGHAI, Jan. 23, 2024 /PRNewswire/ — In the recent World Retail Elite…
From Surviving to Striving: Comexposium Asia Pacific's exciting leadership shift in 2024

From Surviving to Striving: Comexposium Asia Pacific's exciting leadership shift in 2024

SINGAPORE, Jan. 23, 2024 /PRNewswire/ — Comexposium, one of the world’s largest…
Gannex's Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH

Gannex's Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH

Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in…
First Myeloma Patient Treated with CAR-T Successfully Discharged

First Myeloma Patient Treated with CAR-T Successfully Discharged

SHANGHAI, Jan. 23, 2024 /PRNewswire/ — In another milestone since the implementation…
European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A)

European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A)

YONGIN, South Korea, Jan. 23, 2024 /PRNewswire/ — GC Biopharma Corp. (006280.KS)…
More enterprises secure early spots at CIIE 2024

More enterprises secure early spots at CIIE 2024

SHANGHAI, Jan. 23, 2024 /PRNewswire/ — Twenty-three companies had signed up early…